What is the most recent earnings date for KNE stock?
KANE BIOTECH INC (KNE.CA) last reported earnings on 11/28/2025.
TSX-V:KNE • CA4838092084
Past quarterly earnings results for KANE BIOTECH INC (KNE.CA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in CAD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | - | - | 8.5K | - | -99.34% | |||
| Q2 2025 | - | - | 28K | - | -95.49% | |||
| Q1 2025 | - | - | 412.5K | - | 694.80% | |||
| Q4 2024 | - | - | 125.9K | - | -15.50% | |||
| Q3 2024 | - | - | 1.283M | - | 78.67% | |||
| Q2 2024 | - | - | 620.4K | - | -5.61% | |||
| Q1 2024 | - | - | 51.9K | - | -92.34% | |||
| Q4 2023 | - | - | 149K | - | -78.46% | |||
| Q3 2023 | - | - | 717.9K | - | 25.57% | |||
| Q2 2023 | - | - | 657.3K | - | -21.71% | |||
| Q1 2023 | - | - | 677.6K | - | 19.84% | |||
| Q4 2022 | - | - | 691.7K | - | 68.01% | |||
| Q3 2022 | - | - | 571.7K | - | 5.62% | |||
| Q2 2022 | - | - | 839.6K | - | 201.26% | |||
| Q1 2022 | - | - | 565.4K | - | 50.37% | |||
| Q4 2021 | - | - | 411.7K | - | 60.01% | |||
| Q3 2021 | - | - | 541.3K | - | 50.11% | |||
| Q2 2021 | - | - | 278.7K | - | 4.19% | |||
| Q1 2021 | - | - | 376K | - | -17.56% | |||
| Q4 2020 | - | - | 257.3K | - | - | |||
| Q3 2020 | - | - | 360.6K | - | - | |||
| Q2 2020 | - | - | 267.5K | - | - | |||
| Q1 2020 | - | - | 456.1K | - | - |
Notes
KANE BIOTECH INC (KNE.CA) last reported earnings on 11/28/2025.
KANE BIOTECH INC (KNE.CA) missed EPS estimates and missed revenue estimates in the most recent quarter.